Halbert Hargrove Global Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.8K	Buy	+600	New	+$23.8K	﹤0.01%	251

Other funds holding BME

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Halbert Hargrove Global Advisors's BME Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in BlackRock Health Sciences Trust (BME) in Q2 2026: 600 shares worth $25.8K. The stake represents ﹤0.01% of the portfolio and ranks #251 among its holdings.

79 funds tracked by Wall St. Rank hold BME as of Q2 2026.

Halbert Hargrove Global Advisors held 600 shares of BlackRock Health Sciences Trust worth $25.8K as of Q2 2026.
BlackRock Health Sciences Trust was a new Halbert Hargrove Global Advisors position in Q2 2026.
BlackRock Health Sciences Trust made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #251 holding.
79 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.